102 related articles for article (PubMed ID: 11684284)
21. Cycloheximide protects HepG2 cells from serum withdrawal-induced apoptosis by decreasing p53 and phosphorylated p53 levels.
Bai J; Cederbaum AI
J Pharmacol Exp Ther; 2006 Dec; 319(3):1435-43. PubMed ID: 16971506
[TBL] [Abstract][Full Text] [Related]
22. Etoposide (VP-16) sensitizes p53-deficient human non-small cell lung cancer cells to caspase-7-mediated apoptosis.
Chiu CC; Lin CH; Fang K
Apoptosis; 2005 May; 10(3):643-50. PubMed ID: 15909125
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of protein PMP22 enhances etoposide-induced cell apoptosis by p53 signaling pathway in Gastric Cancer.
Hou J; Wang L; Zhao J; Zhuo H; Cheng J; Chen X; Zheng W; Hong Z; Cai J
Int J Biol Sci; 2021; 17(12):3145-3157. PubMed ID: 34421356
[TBL] [Abstract][Full Text] [Related]
24. New alternative phosphorylation sites on the cyclin dependent kinase 1/cyclin a complex in p53-deficient human cells treated with etoposide: possible association with etoposide-induced apoptosis.
Higginbottom K; Jahnke U; Newland AC; Cotter FE; Allen PD
Apoptosis; 2007 Oct; 12(10):1847-55. PubMed ID: 17636382
[TBL] [Abstract][Full Text] [Related]
25. [p33(ING1b) enhances chemosensitivity of osteosarcoma cell U2OS to etoposide].
Zhu JJ; Liao WM; Li FB; Zhu XF; Zhou JM; Liu ZC
Ai Zheng; 2004 Jun; 23(6):640-4. PubMed ID: 15191662
[TBL] [Abstract][Full Text] [Related]
26. CBFbeta-SMMHC, expressed in M4eo acute myeloid leukemia, reduces p53 induction and slows apoptosis in hematopoietic cells exposed to DNA-damaging agents.
Britos-Bray M; Ramirez M; Cao W; Wang X; Liu PP; Civin CI; Friedman AD
Blood; 1998 Dec; 92(11):4344-52. PubMed ID: 9834241
[TBL] [Abstract][Full Text] [Related]
27. Effect of wild-type and mutant E-cadherin on cell proliferation and responsiveness to the chemotherapeutic agents cisplatin, etoposide, and 5-fluorouracil.
Fricke E; Hermannstädter C; Keller G; Fuchs M; Brunner I; Busch R; Höfler H; Becker KF; Luber B
Oncology; 2004; 66(2):150-9. PubMed ID: 15138368
[TBL] [Abstract][Full Text] [Related]
28. Etoposide Induces Necrosis Through p53-Mediated Antiapoptosis in Human Kidney Proximal Tubule Cells.
Kwon HK; Shin HJ; Lee JH; Park SH; Kwon MC; Panneerselvam S; Lee CG; Kim SG; Kim JH; Choi S
Toxicol Sci; 2015 Nov; 148(1):204-19. PubMed ID: 26259609
[TBL] [Abstract][Full Text] [Related]
29. Proteasome inhibitors potentiate etoposide-induced cell death in human astrocytoma cells bearing a mutated p53 isoform.
Ceruti S; Mazzola A; Abbracchio MP
J Pharmacol Exp Ther; 2006 Dec; 319(3):1424-34. PubMed ID: 16971507
[TBL] [Abstract][Full Text] [Related]
30. "Loop" domain is necessary for taxol-induced mobility shift and phosphorylation of Bcl-2 as well as for inhibiting taxol-induced cytosolic accumulation of cytochrome c and apoptosis.
Fang G; Chang BS; Kim CN; Perkins C; Thompson CB; Bhalla KN
Cancer Res; 1998 Aug; 58(15):3202-8. PubMed ID: 9699642
[TBL] [Abstract][Full Text] [Related]
31. Mutated and non-mutated TP53 as targets in the treatment of leukaemia.
Nahi H; Selivanova G; Lehmann S; Möllgård L; Bengtzen S; Concha H; Svensson A; Wiman KG; Merup M; Paul C
Br J Haematol; 2008 May; 141(4):445-53. PubMed ID: 18341636
[TBL] [Abstract][Full Text] [Related]
32. Etoposide induces G2/M arrest and apoptosis in neural progenitor cells via DNA damage and an ATM/p53-related pathway.
Nam C; Doi K; Nakayama H
Histol Histopathol; 2010 Apr; 25(4):485-93. PubMed ID: 20183801
[TBL] [Abstract][Full Text] [Related]
33. A molecular evaluation of germ cell death induced by etoposide in pubertal rat testes.
Ortiz RJ; Lizama C; Codelia VA; Moreno RD
Mol Hum Reprod; 2009 Jun; 15(6):363-71. PubMed ID: 19346530
[TBL] [Abstract][Full Text] [Related]
34. Loss of histone H2AX increases sensitivity of immortalized mouse fibroblasts to the topoisomerase II inhibitor etoposide.
Donà F; Prosperi E; Savio M; Coppa T; Scovassi AI; Mondello C
Int J Oncol; 2008 Sep; 33(3):613-21. PubMed ID: 18695893
[TBL] [Abstract][Full Text] [Related]
35. Pifithrin-alpha, an inhibitor of p53, enhances the genetic instability induced by etoposide (VP16) in human lymphoblastoid cells treated in vitro.
Bassi L; Carloni M; Fonti E; Palma de la Peña N; Meschini R; Palitti F
Mutat Res; 2002 Feb; 499(2):163-76. PubMed ID: 11827710
[TBL] [Abstract][Full Text] [Related]
36. Combretastatin-A4 prodrug induces mitotic catastrophe in chronic lymphocytic leukemia cell line independent of caspase activation and poly(ADP-ribose) polymerase cleavage.
Nabha SM; Mohammad RM; Dandashi MH; Coupaye-Gerard B; Aboukameel A; Pettit GR; Al-Katib AM
Clin Cancer Res; 2002 Aug; 8(8):2735-41. PubMed ID: 12171907
[TBL] [Abstract][Full Text] [Related]
37. Expression of wild-type p53 increases etoposide cytotoxicity in M1 myeloid leukemia cells by facilitated G2 to M transition: implications for gene therapy.
Skladanowski A; Larsen AK
Cancer Res; 1997 Mar; 57(5):818-23. PubMed ID: 9041178
[TBL] [Abstract][Full Text] [Related]
38. FGF1 protects neuroblastoma SH-SY5Y cells from p53-dependent apoptosis through an intracrine pathway regulated by FGF1 phosphorylation.
Pirou C; Montazer-Torbati F; Jah N; Delmas E; Lasbleiz C; Mignotte B; Renaud F
Cell Death Dis; 2017 Aug; 8(8):e3023. PubMed ID: 29048426
[TBL] [Abstract][Full Text] [Related]
39. Superior anti-tumor activity of the MDM2 antagonist idasanutlin and the Bcl-2 inhibitor venetoclax in p53 wild-type acute myeloid leukemia models.
Lehmann C; Friess T; Birzele F; Kiialainen A; Dangl M
J Hematol Oncol; 2016 Jun; 9(1):50. PubMed ID: 27353420
[TBL] [Abstract][Full Text] [Related]
40. Drug resistance towards etoposide and cisplatin in human melanoma cells is associated with drug-dependent apoptosis deficiency.
Helmbach H; Kern MA; Rossmann E; Renz K; Kissel C; Gschwendt B; Schadendorf D
J Invest Dermatol; 2002 Jun; 118(6):923-32. PubMed ID: 12060385
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
